Skip to content

Buying a Pharmacy

First-Time Pharmacy Buyer: Finance and Affordability

11 November 2026 · 9 min read

Get in touch

The short answer: can you afford it?

The affordability test for buying a pharmacy has three components: whether your deposit (from savings, equity, or other sources) covers the lender's required stake; whether the loan repayments fit within projected income; and whether post-tax cash from the pharmacy's projected profit covers annual debt service and leaves a drawings buffer. All three must pass. Failing one means the purchase is unaffordable at the proposed price, regardless of how attractive the opportunity looks on the surface. The pharmacy purchase affordability calculator walks through each component in turn as a scenario estimate.

Deposit percentages and lender rates are set by each lender for each deal, so what's worth knowing is how the arithmetic works: it lets you sense-check a deal before you commit to professional fees and legal costs.

The three inputs: deposit, loan, and post-tax cash cover from projected profit

Every pharmacy affordability assessment starts with the same three numbers. The interplay between them is easy to underestimate.

The deposit

The deposit is the portion of the purchase price you fund without borrowing. Lenders set their own deposit requirements based on the deal, the quality of the accounts, the pharmacy's income mix, and their own appetite at the time. No universal percentage applies, and any figure you see quoted online is a broker's illustrative example, not a guarantee.

What matters for your planning is the source of the deposit: personal savings, equity release from another property, or a combination. Each source has different tax and cash-flow implications that a pre-purchase review should map out before you approach a lender.

The loan

The loan covers the gap between the purchase price and the deposit. A pharmacy loan is a commercial loan rather than a residential mortgage, structured around the business's ability to service the debt from income. The loan term, interest rate, and repayment structure are agreed with the lender and directly determine the annual debt-service figure the pharmacy's post-tax profit must exceed.

Post-tax cash cover from projected profit

This is the test that's easiest to get wrong. The figure that matters is not the pharmacy's headline profit or adjusted EBITDA. It is the cash left after tax.

  • If you are buying through a company, corporation tax applies first. The main rate is 25% on profits above £250,000 and 19% on profits up to £50,000, with marginal relief between the two thresholds (those limits are split across the company and any associated companies, so a company with three associates gets a quarter of each). See HMRC corporation tax rates.
  • If you are buying as a sole trader or partnership, income tax and Class 4 NIC apply instead, at the relevant bands for your total income.
  • Dividend extraction from a company adds a second layer: dividends are paid from post-corporation-tax profit and then taxed at 10.75%, 35.75%, or 39.35% (FA 2026 rates for 2026/27) with a £500 dividend allowance. Salary/dividend mix planning is part of the true cost of ownership.

Once you know the post-tax cash figure, the affordability test is:

Post-tax cash minus annual debt service (capital plus interest) minus a drawings buffer = headroom.

Positive headroom means the purchase is cash-flow affordable at the projected profit level. Thin or negative headroom means the price, the loan structure, or the projected income need to change.

Illustrative affordability worksheet (example figures only)

These figures show the structure of the calculation, not a real-world outcome. They're illustrative and internally consistent, for a company buyer with no associated companies and a 12-month accounting period. They are not a lender's offer and not a guarantee of any particular result.

Line Illustrative amount Note
Purchase price £500,000 Example only
Deposit (£100,000) Buyer's own funds
Loan required £400,000 To be agreed with lender
Projected adjusted profit (before interest and tax) £80,000 From vendor's accounts, adjusted
Loan interest, year one (illustrative) (£25,000) Part of the £40,000 annual debt service; a company deducts it before corporation tax
Corporation tax on £55,000 (£10,825) 25% less marginal relief (3/200 of £195,000); actual tax depends on associated companies and profit level
Post-tax profit available £44,175
Loan capital repaid, year one (illustrative) (£15,000) The rest of the £40,000 debt service; lender-specific, not a quoted rate
Drawings buffer required (£30,000) Living costs, owner-specific
Headroom (£825) Negative: purchase is unaffordable at these figures

In this example, the projected profit does not cover both debt service and drawings at the proposed price. The buyer would need to renegotiate the price, increase the deposit, or identify a higher-profit pharmacy. The purchase affordability calculator lets you adjust each variable to find where headroom turns positive. It is a scenario tool, states its simplifications, and ends at "your situation warrants a specialist review", not at a specific lender offer.

Add the purchase price, deposit, loan terms and projected profit to see the monthly repayment, the post-tax cash cover and the stamp duty or SDLT on a share deal against an asset deal.

Calculator

Pharmacy Purchase Affordability Calculator

Enter the purchase price, deposit, loan terms and projected pharmacy profit to see your estimated loan repayments, how well trading cash flow covers the debt, and the acquisition tax cost for a share deal versus an asset deal. Every figure already in the boxes is an example, so replace it with your own; the result on your deal depends on how it's structured.

£

The agreed headline price for the pharmacy. Enter the actual figure from your heads of terms.

£

The amount you are putting in from your own funds. The rest is assumed to be financed by a commercial loan.

The term your lender offers. Shorter terms mean higher repayments but less total interest.

The rate quoted by the lender. The rate you are offered depends on lender, term and loan-to-value.

£

The part of the price that buys land or buildings: a freehold, or what you pay for a lease. Leave at 0 if no property is being bought. SDLT is charged on this figure only, never on goodwill or the NHS contract.

£

Only if you're taking a new lease of the premises. SDLT is due on the rent's net present value at 1% from £150,001 to £5 million and 2% above. HMRC's SDLT calculator works the figure out from the rent and the term.

£

The adjusted EBITDA or trading profit you expect after your salary, before loan interest and tax. The tool takes the first year's interest off before working out corporation tax.

Your result

Your answer's ready. Press below to see it.

Why the NHSBSA payment lag matters to affordability

Pharmacy income is contract-driven, not till-driven. The primary income source is NHS reimbursement under the Community Pharmacy Contractual Framework, not shop takings. As a result, the cash-flow pattern is unlike most retail businesses.

FP34 prescriptions are submitted monthly to the NHSBSA, which advances the full estimated value about ten days after the month ends and settles up some two months after submission. So in the first weeks of ownership you are dispensing and staffing before the first advance arrives. A working-capital buffer is still needed on day one, in addition to the deposit and legal costs of the purchase.

First-time buyers who model affordability on the pharmacy's annual profit figure without accounting for this timing gap can find themselves cash-constrained immediately after completion, even if the underlying business is profitable. Finance-ready accounts and a cash-flow projection that shows the NHSBSA payment cycle are part of what a specialist buyer review covers. For more on FP34 mechanics, see our NHS payment reconciliation service.

Want this checked against your specific situation?

Leave your details and a one-line summary. One of our specialists will come back to you, with no obligation.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.

What "finance-ready accounts" means

Lenders and professional advisers assessing a pharmacy purchase need accounts that go beyond what a standard bookkeeper produces. Finance-ready accounts for a pharmacy have four characteristics.

Clean and reconciled

NHS income is reconciled back to NHSBSA schedules, not just recognised as a bank receipt. VAT is correctly split between zero-rated prescription dispensing and standard-rated OTC retail, as set out in HMRC Notice 701/57. A pharmacy is a VAT-mixed business and the split matters because it affects both the true revenue figure and the VAT reclaim position. Unreconciled accounts mask the real margin and raise questions a buyer's adviser will need to resolve before recommending proceeding.

Margin story evidenced

Drug Tariff prices are set centrally, and DHSC resets Category M prices each quarter (an item earns whatever the Tariff listed for the month you dispensed it). That means gross margin is not fixed; it varies with Drug Tariff revisions and can be affected by clawback. Finance-ready accounts show the margin trend over at least two full years, explain any significant variations, and present an adjusted EBITDA that removes one-off items so the ongoing earning capacity is visible.

Service income separately tracked

Pharmacy First and similar service payments are a separately accounted income line with their own fee structure. Accounts that lump service income into general turnover make it harder to assess how dependent the business is on dispensing volume versus growing service revenue.

Where the vendor has run personal costs through the business, or where the owner-pharmacist's salary is above or below a market locum rate, adjusted EBITDA must be restated to reflect the true cost of operating under new ownership. Lenders and advisers will do this adjustment themselves if the accounts do not; the cleaner the starting point, the less uncertainty there is about the adjustment.

Finance-ready accounts checklist

Item Why a lender or adviser needs it
2 to 3 years of filed statutory accounts Trend visibility; consistency check against management accounts
NHSBSA payment schedules reconciled to P&L Confirms revenue is real and correctly timed
VAT returns showing zero-rated / standard-rated split Verifies the VAT-mixed position and reclaim accuracy
Drug Tariff adjustment history (at least 12 months) Shows margin stability and clawback exposure
Adjusted EBITDA schedule (one-offs removed, owner costs normalised) Establishes the true ongoing earning capacity
Dispensing volume history (items per month) Cross-checks revenue and shows trajectory
Service income breakdown (Pharmacy First, other) Separates growing service revenue from core dispensing income
Cash-flow forecast showing NHSBSA payment lag Models working-capital requirement in first months of ownership

How the numbers actually stack: a method-level walk-through

A pharmacy purchase price can be derived from a multiple of adjusted EBITDA and cross-checked against a pence-per-item benchmark on dispensing volume. Neither method produces a single correct answer, and the multiple and benchmark vary with the pharmacy, the contract terms, the location, and current market conditions. We do not publish a specific multiple because no single figure holds across deals.

What the method tells you is this: the higher the price relative to adjusted EBITDA, the more years of post-tax profit are needed to service the acquisition debt. A purchase at a high multiple with thin margins produces a tight debt-service cover ratio. A purchase at a lower multiple with a growing Pharmacy First income line and stable dispensing volume may be strongly affordable at the same absolute price. The arithmetic, not the headline multiple, is the test.

Running the affordability worksheet for yourself, with the actual accounts and a realistic loan structure, is the only way to know whether a specific pharmacy is affordable for your specific financial position. The purchase affordability calculator is built to do this work without requiring a spreadsheet, but it is a scenario tool and does not produce a lender offer or a tax return figure.

Structure affects affordability: share purchase versus asset purchase

The legal structure of the deal changes what you are financing and what the tax costs of entry are, both of which affect affordability.

In a share purchase, you buy the company that holds the NHS contract and the pharmacy business. Stamp duty of 0.5% on the share consideration applies on a transaction over £1,000, until the announced Securities Transfer Tax replaces stamp duty on shares (due in late 2027, by commencement order). You also inherit the company's history, including any historic tax liabilities, so pre-purchase due diligence is more extensive. The NHS contract stays in the company, avoiding a separate NHS contract transfer process.

In an asset purchase, you buy the individual assets (goodwill, stock, fixtures) rather than the company. If property is included, SDLT at non-residential rates up to 5% applies. Goodwill dominates pharmacy pricing (driven by the NHS contract and dispensing volume), and corporation tax relief on goodwill acquired by a company is restricted: relief comes only when the company also buys qualifying IP, and then at 6.5% a year on goodwill worth up to six times the IP's cost. That lowers the after-tax value of the deal for a company buyer.

The structure decision also changes the regulatory steps. On an asset purchase you apply to NHS England to take the seller's place in the pharmaceutical list (regulation 26 of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013); on a share purchase the company keeps its listing and gives NHS England notice, within 30 days, of any change of directors or superintendent. The premises entry in the GPhC register depends on whoever lawfully runs the pharmacy there (Medicines Act 1968 ss74A, 74B). The deep-dive on share versus asset is in our share versus asset purchase guide. For affordability purposes, note that the entry tax costs (stamp duty, SDLT) are part of the total cash needed on day one, not just the purchase price.

What a specialist checks before you commit

A pre-purchase accounting review does several things a lender or solicitor will not do for you.

  • It reconstructs adjusted EBITDA from the vendor's accounts, removing one-offs and normalising owner costs, to give a defensible post-tax cash figure before you negotiate the price.
  • It maps the NHSBSA payment lag against your available working capital to confirm you will not run short in the first quarter.
  • It reviews the VAT-mixed position and flags any historic errors that become your liability in a share purchase.
  • It models the post-tax cash cover under your planned ownership structure (company or sole trader, salary and dividend mix) so the headroom figure is your actual headroom, not a vendor's illustration.
  • It checks how the price is split between goodwill and fit-out assets, which decides the goodwill relief and the capital allowances on the equipment, and so your year-one and year-two tax.

If you are at an early stage and want to run the numbers before instructing specialists, start with the pharmacy purchase affordability calculator. If you are closer to a deal and need a detailed pre-purchase review, our pharmacy purchase accounting service covers the full scope above. For a broader overview of the process from search to completion, the buying a pharmacy checklist sets out each stage. For the audience hub with links to all buying-related resources, see buying a pharmacy.

This post gives general accounting and tax information about pharmacy purchase affordability. It is not financial promotion, lending advice, or a personal recommendation. Figures described as illustrative are examples only and do not represent any lender's criteria or a guaranteed outcome. Speak to a qualified specialist before making any purchase decision.

Frequently asked questions

No single figure applies across lenders and deals. The deposit requirement depends on the lender, the deal structure, the quality of the accounts, and the pharmacy's income mix. Running the scenario through the purchase affordability calculator gives a structured starting point, but the real figure comes from a lender conversation backed by finance-ready accounts.

The affordability test uses post-tax profit (after corporation tax for a company buyer, or income tax and Class 4 NIC for a sole trader), not headline profit. That post-tax figure must cover annual debt service (capital plus interest) and leave a drawings buffer. If headroom is thin at projected volumes, the purchase may be unaffordable at the proposed price.

Finance-ready accounts are clean, reconciled, and margin-evidenced. They separate NHS reimbursement income from OTC retail, show the VAT-mixed position correctly, explain margin movements from quarterly Category M price changes, and present adjusted EBITDA in a way a lender or professional adviser can verify rather than having to reconstruct.

Declare the month's prescriptions by the 5th and NHSBSA pays its estimate of the whole claim around the 10th, with a reconciliation about two months after you submit. You still pay for the first month's stock and wages before that first advance lands, so a pharmacy needs a working-capital buffer in the first weeks of ownership, which is a day-one cash need on top of the purchase price itself.

Both, but NHS contract income is the core underwriting story for a dispensing pharmacy. Lenders want to see a stable dispensing volume, a clear margin story, and accounts that correctly reconcile NHSBSA payments, not just till-level retail turnover.

Borrowing capacity is lender-specific and depends on the verified post-tax cash cover, the deal structure, and the quality of the accounts. No published multiple applies universally. A specialist review of the projected accounts against the purchase price is the only reliable starting point.

Related reading

Need help with your pharmacy finances?

Tell us about your situation and we will come back within 24 hours.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)